Mackenzie Financial »

BioCryst Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $221k 29k 7.60
2024-06-30 $173k 28k 6.18
2024-03-31 $164k 32k 5.08
2023-12-31 $140k 23k 5.99
2023-09-30 $86k 13k 6.42
2023-06-30 $367k 52k 7.05
2023-03-31 $491k 59k 8.34
2022-12-31 $245k 21k 11.48
2022-09-30 $663k 53k 12.61
2022-06-30 $250k 24k 10.57
2022-03-31 $290k 18k 16.29
2021-09-30 $150k 10k 14.39